profit from every $100 of sales.
$0$100
Albemarle
$95.97+1.10% today
-7.6% in 1 year
1-year low $90.191-year high $215.62
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Albemarle sold, what it kept, and what it did with the cash.
Sales went from $7.32 billion in 2022 to $5.14 billion in 2025, with -$511 million of profit last year.
SalesProfit
Albemarle handed back 52% of the cash it generated last year.
$357M
Free cash flow 2025$692M
Bought back its own shares–
Paid as dividends$357M
Cash vs. debt$1.6B vs. $3.3B
Albemarle vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Albemarle | No profit yet | ||
 PPG Industries | 17.5× · Fair price | ||
 International Flavors & Fragrances | No profit yet | ||
 DuPont de Nemours | No profit yet | ||
 LyondellBasell Industries | No profit yet |
Compare Albemarle with DuPont de Nemours · Dow
AI analysis
An AI analyst reads Albemarle's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 3,129 | 3,328 | 7,320 | 9,617 | 5,378 | 5,143 | |
| 995 | 998 | 3,075 | 1,186 | 63 | 669 | |
| – | – | 2,478 | 190 | -642 | 67 | |
| 679 | 449 | 2,857 | 793 | -1,010 | 314 | |
| 376 | 124 | 2,690 | 1,573 | -1,179 | -511 | |
| 3.52 | 1.06 | 22.84 | 13.36 | -11.20 | -5.76 | |
| 31.8% | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% | |
| – | – | 33.9% | 2.0% | -11.9% | 1.3% | |
| 12.0% | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 10,451 | 10,974 | 15,457 | 18,271 | 16,610 | 16,374 |
| Cash | 747 | 439 | 1,499 | 890 | 1,192 | 1,618 |
| Total debt | 3,689 | 2,521 | 3,316 | 4,280 | 3,616 | 3,297 |
| Total liabilities | – | – | 7,266 | 8,606 | 6,410 | 6,593 |
| 4,268 | 5,625 | 7,983 | 9,412 | 9,962 | 9,533 | |
| 107 | 117 | 118 | 118 | 118 | 118 | |
| 4.4% | 1.9% | 17.9% | 2.1% | -9.3% | -2.1% | |
| 8.8% | 2.2% | 33.7% | 16.7% | -11.8% | -5.4% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 799 | 344 | 1,908 | 1,327 | 688 | 1,282 | |
| 850 | 954 | 1,262 | 2,155 | 1,681 | 590 | |
| -52 | -609 | 646 | -828 | -993 | 692 | |
| Dividends paid | – | – | 184 | 187 | 311 | 357 |
| 0 | – | – | – | – | – | |
| 23 | 20 | 30 | 37 | 32 | 40 |
Valuation
- –
- 11.4×
- –
- 2.2×
- 2.2×
- 16.4×
- 41.4×
- 6.1%
- -4.5%
- 0.9%
Profitability
- 13.0%
- 1.3%
- -9.9%
- 14.6%
- 2.2%
- 4.8%
- -2.4%
- -1.5%
- 2.2%
- 0.8%
Growth
- +10.4%
- –
- +169.8%
- +1.0%
- +0.4%
Financial health
- 1.0×
- 0.19
- 12.4%
- 1.6×
- 2.07
- 1.21
- 0.36
How it ranks in Materials
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 24%of 989
Bottom 15%of 958
Top 30%of 935
Top 24%of 990
What analysts expect
- Average price target
- $190.80
- Range
- $136.00 – $245.00
- 10 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 2.95 | 1.24 | +137.9% |
| Feb 11, 2026 | -0.53 | -0.42 | −26.8% |
| Nov 5, 2025 | -0.19 | -0.86 | +77.9% |
| Jul 30, 2025 | 0.11 | -0.83 | +113.3% |
| Apr 30, 2025 | -0.18 | -0.62 | +71.0% |
| Feb 12, 2025 | -1.09 | -0.60 | −81.7% |
| Nov 6, 2024 | -1.55 | -0.44 | −253.2% |
| Jul 31, 2024 | 0.04 | 0.53 | −92.5% |
0.9%of the share price, paid each year
On $1,000 invested$9a year at today's yield, before tax
+1.0%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$1.16 in 2015 → $1.62 in 2025
How safe it looks
-153.4% of its profit
Room to growStretchedMore than it earns: 51.6%
News
Albemarle upgraded at Mizuho on surging energy storage demandSeeking Alpha · Oct 14, 2026Albemarle Corporation (ALB) is Attracting Investor Attention: Here is What You Should KnowYahoo Finance · Sep 18, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
42No pass
Philip Fisher
26No pass
Peter Lynch
45No pass
Joel Greenblatt
0No pass
Charlie Munger
24No pass
Terry Smith
20No pass
Questions about Albemarle
Is Albemarle a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Albemarle AI analysis
What does Albemarle do?
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. It is in Chemicals - Specialty, based in Charlotte, NC, United States, with 7,800 employees.
Does Albemarle pay a dividend?
Yes. At today's price the dividend is 0.9% a year. In 2025 it paid out $357 million in dividends.
Is Albemarle stock halal?
Yes. Albemarle passes our halal screen: its business is permitted and its debt is 29% of its market value, under the 30% limit. How we check
How has Albemarle stock done over the past year?
Down 7.6% over the past twelve months, to $95.97. It traded between $90.19 and $215.62 and is 55.5% below its high.
Who are Albemarle's competitors?
The largest listed companies in the same industry are PPG Industries, International Flavors & Fragrances, DuPont de Nemours and LyondellBasell Industries. The peers table on this page compares their profit, growth and price with Albemarle's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.